OLAREGEN THERAPEUTIX
Olaregen Therapeutix is a regenerative medicine company focused on the development, manufacturing and commercialization of products that fill unmet needs in the current wound care market. The company aims to provide advanced healing solutions that substantially improve medical outcomes while lowering the overall cost of care. Olaregen's first product introduction, Excellagen (flowable dermal matrix) is a topically applied product for dermal wounds and other indications. The company is focused in... advancing wound care including diabetic foot ulcers (DFU), venous leg ulcers and pressure ulcers. Future products focusing on innovative therapies in bone and joint regeneration comprise the current pipeline. The company's mission is to become a significant force in regenerative medicine and advance the science of healing.
OLAREGEN THERAPEUTIX
Industry:
Biotechnology Pharmaceutical
Founded:
2017-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.olaregen.com
Total Employee:
1+
Status:
Active
Contact:
+631-495-3467
Total Funding:
450 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Cygnal Therapeutics
Cygnal Therapeutics is a biotechnology company
Rekindle Therapeutics
Rekindle Therapeutics is a biotechnology company.
RNADerm Therapeutics
RNADerm Therapeutics is a biotechnology company.
Current Employees Featured
Founder
Official Site Inspections
http://www.olaregen.com
- Host name: 22.113.180.107.host.secureserver.net
- IP address: 107.180.113.22
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Olaregen Therapeutix"
Olaregen Therapeutix - Crunchbase Company Profile & Funding
Olaregen Therapeutix is a regenerative medicine company focused on the development, manufacturing and commercialization of products that fill unmet needs in the current wound …See details»
Generex Biotechnology Completes Acquisition of Olaregen …
Recent acquisitions include a management services organization, a network of pharmacies, clinical laboratory, and medical device companies with new and approved products. ...See details»
Olaregen Therapeutix - VentureRadar
Olaregen Therapeutix, Inc. is a regenerative medicine company focused on the development, manufacturing and commercialization of products that fill unmet needs in the current wound …See details»
Olaregen Therapeutix - LinkedIn
Olaregen Therapeutix, Inc. is a regenerative medicine company focused on the development, manufacturing and commercialization of products that fill unmet needs in current wound …See details»
Olaregen Therapeutix Company Profile 2024: Valuation, Investors ...
Olaregen Therapeutix was founded in 2017. Where is Olaregen Therapeutix headquartered? Olaregen Therapeutix is headquartered in New York, NY. What is the size of Olaregen …See details»
Generex Biotechnology Expands Medical Device Portfolio With …
Nov 28, 2018 Olaregen Therapeutix, Inc. is a regenerative medicine company focused on the development, manufacturing and commercialization of products that fill unmet needs in the …See details»
Olaregen Therapeutix Inc - Company Profile and News
Company profile page for Olaregen Therapeutix Inc including stock price, company news, executives, board members, and contact informationSee details»
Generex Biotechnology Completes Acquisition of Olaregen
Jan 8, 2019 MIRAMAR, Fla.--(BUSINESS WIRE)-- Generex Biotechnology Corporation (OTCQB:GNBT) is pleased to announce that the company has completed the acquisition of …See details»
Olaregen Therapeutix - Craft
Olaregen Therapeutix is a regenerative medicine company focused on the development, manufacturing, and commercialization of products that advance healing and improve patients' …See details»
Generex Biotechnology Completes Acquisition of Olaregen …
Jan 8, 2019 MIRAMAR, Fla. — Generex Biotechnology Corporation (OTCQB:GNBT) is pleased to announce that the company has completed the acquisition of 51% of Olaregen Therapeutix…See details»
Generex Biotechnology Subsidiary Olaregen Therapeutix Inc. Plans …
Olaregen’s decision to manufacture a 0.5cc and a 0.8cc for smaller wounds such as ... Recent acquisitions include a management services organization, a network of pharmacies, clinical …See details»
Generex Biotechnology Completes Acquisition of Olaregen …
Jan 8, 2019 Contacts. Generex Biotechnology Corporation Joseph Moscato 646-599-6222 . Todd Falls 800-391-6755 Extension 222 . [email protected]See details»
Generex Biotechnology Expands Medical Device Portfolio with …
Olaregen, which was established with the primary purpose of commercializing Excellagen , a proprietary, patented, advanced wound healing product that has been FDA cleared based on …See details»
Generex Biotechnology Corporation Subsidiary, Olaregen
Jul 26, 2021 Olaregen's first product introduction, Excellagen® (flowable dermal matrix) is a topically applied product for dermal wounds and other indications. Excellagen is an FDA 510K …See details»
Generex Biotechnology Subsidiary Olaregen Therapeutix ... - Nasdaq
Aug 13, 2020 Olaregen Therapeutix, Inc. is a regenerative medicine company focused on the development, manufacturing and commercialization of products that fill unmet needs in the …See details»
Generex Biotechnology Subsidiary Olaregen Therapeutix …
May 3, 2021 About Olaregen Therapeutics Olaregen Therapeutix, Inc. is a regenerative medicine company focused on the development, manufacturing and commercialization of …See details»
Generex Biotechnology Partner Olaregen Therapeutix Inc.
About Olaregen Therapeutics Olaregen Therapeutix, Inc. is a regenerative medicine company focused on the development, manufacturing and commercialization of products that fill unmet …See details»
Generex Biotechnology Subsidiary Olaregen Therapeutix …
Aug 13, 2020 Olaregen's first product introduction, Excellagen (flowable dermal matrix) is a topically applied product for dermal wounds and other indications. Excellagen is a FDA 510K …See details»
Generex Biotechnology Subsidiary Olaregen Therapeutix Signs …
Sep 30, 2019 Olaregen Therapeutix, Inc. is a regenerative medicine company focused on the development, manufacturing and commercialization of products that fill unmet needs in the …See details»
Generex Biotechnology Subsidiary Olaregen Therapeutix …
Recent acquisitions include a management services organization, a network of pharmacies, clinical laboratory, and medical device companies with new and approved products. Our newly …See details»